← Open Payments lookup

AMY WHITSA: Open Payments

NPI 1487322921 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$300 in 14 payments from 9 companies in 2025. Trend: 2023 $492 · 2024 $202 · 2025 $300

Food & beverage: $300
CompanyPaymentsAmount
Amgen Inc.6$135
Azurity Pharmaceuticals, Inc.1$24
Novo Nordisk Inc1$24
KYOWA KIRIN, INC.1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
GlaxoSmithKline, LLC.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
BETA BIONICS, INC.1$16
Bayer Healthcare Pharmaceuticals Inc.1$15

Products named: EVENITY, HORIZANT, CRYSVITA, JARDIANCE, BEXSERO, CAPLYTA, iLet Bionic Pancreas, Kerendia.

Industry payments across OR — which companies pay providers there.